Edwards Lifesciences Corp vs Abbvie Inc.
EW vs ABBV — side-by-side comparison from reported financials. EW leads 5, ABBV leads 5 of 10 comparable metrics.
Edwards Lifesciences Corp
EW · Healthcare
$85.21+1.15%Strong
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | EW | ABBV |
|---|---|---|
| Price | $85.21 | $276.43 |
| Market cap | $49.1B | $488B |
| Revenue (TTM) | $6.51B | $64.4B |
| Revenue growth | +4.1% | +1.8% |
| Net margin | 15.4% | 9.8% |
| Free cash flow | $1.43B | $18.2B |
| Net cash (debt) | $3.63B | ($56.2B) |
| 1-year price return | +13.3% | +19.8% |
| P/E | 48.9 | 77.4 |
| P/E vs own history (cheap-side %) | 11% | 23% |
| Dividend yield | — | 2.45% |
| Return on equity | 10% | 96% |
| Altman Z-score | 11.86 | 2.33 |
| CV checks passed | 9 of 10 | 9 of 10 |
| Employees | 16,000 | 57,000 |
Full résumé-style profiles: EW CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.